Biocon faces regulatory heat as USFDA flags critical issues at its Bengaluru facility
In a significant development that has sent shockwaves through the biotechnology industry, Biocon Ltd. has come under fire from the U.S. Food and Drug Administration ... Read More
Biocon joins forces with Tabuk Pharmaceuticals to bring GLP-1 diabetes drugs to Middle East
In a strategic move to tackle the growing diabetes crisis in the Middle East, Biocon Limited has announced a partnership with Tabuk Pharmaceutical Manufacturing Company. ... Read More